SHANE MORGAN: Open Payments
NPI 1437142213 · LINCOLN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,996 in 261 payments from 21 companies in 2025. Trend: 2023 $5,679 · 2024 $5,732 · 2025 $4,996
Food & beverage: $4,787Education: $209
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 76 | $861 |
| Janssen Biotech, Inc. | 30 | $815 |
| LEO Pharma Inc. | 24 | $622 |
| Novartis Pharmaceuticals Corporation | 19 | $413 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $296 |
| PFIZER INC. | 11 | $295 |
| UCB, Inc. | 10 | $260 |
| Regeneron Healthcare Solutions, Inc. | 7 | $229 |
| E.R. Squibb & Sons, L.L.C. | 13 | $209 |
| Arcutis Biotherapeutics, Inc. | 14 | $205 |
Products named: TREMFYA, ADBRY, SKYRIZI, DUPIXENT, COSENTYX, CIBINQO, RINVOQ, Bimzelx.
Industry payments across RI — which companies pay providers there.
